Tirzepatide, a novel medication, is sparking significant interest in the scientific community as a viable treatment for both type 2 diabetes and reducing body fat. This groundbreaking drug works by targeting two distinct receptors, GLP-1 and GIP, leading to enhanced blood sugar levels and substantial fat loss in clinical trials . While initial d… Read More